Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference
Quest Diagnostics (NYSE: DGX) announced that Chairman, CEO and President Jim Davis will deliver a presentation at the William Blair 45th Annual Growth Stock Conference in Chicago. The presentation is scheduled for June 3, 2025, at 11:00 a.m. Eastern Time.
During the presentation, Davis will discuss the company's strategy, performance, and current market trends. Investors can access the live webcast through Quest's investor relations page at ir.QuestDiagnostics.com. The archived version will be available within 24 hours after the event and remain accessible until July 3, 2025.
[]Quest Diagnostics (NYSE: DGX) ha annunciato che il Presidente, CEO e Presidente Jim Davis terrà una presentazione al William Blair 45° Annual Growth Stock Conference a Chicago. La presentazione è programmata per il 3 giugno 2025 alle 11:00 ora orientale.
Durante la presentazione, Davis parlerà della strategia dell'azienda, delle sue performance e delle tendenze attuali del mercato. Gli investitori potranno seguire la diretta streaming tramite la pagina delle relazioni con gli investitori di Quest all'indirizzo ir.QuestDiagnostics.com. La versione registrata sarà disponibile entro 24 ore dall'evento e resterà accessibile fino al 3 luglio 2025.
Quest Diagnostics (NYSE: DGX) anunció que el Presidente, CEO y Presidente Jim Davis realizará una presentación en la 45ª Conferencia Anual de Acciones de Crecimiento de William Blair en Chicago. La presentación está programada para el 3 de junio de 2025 a las 11:00 a.m., hora del Este.
Durante la presentación, Davis hablará sobre la estrategia de la empresa, su desempeño y las tendencias actuales del mercado. Los inversores podrán acceder a la transmisión en vivo a través de la página de relaciones con inversores de Quest en ir.QuestDiagnostics.com. La versión archivada estará disponible dentro de las 24 horas posteriores al evento y permanecerá accesible hasta el 3 de julio de 2025.
Quest Diagnostics (NYSE: DGX)ëŠ� 회장 ê²� CEO ë°� 사장ì� Jim Davisê°€ ì‹œì¹´ê³ ì—ì„� 열리ëŠ� William Blair ì �45íš� ì—°ë¡€ 성장ì£� 컨í¼ëŸ°ìФì—서 발표ë¥� í•� 것ì´ë¼ê³ 발표했습니다. 발표ëŠ� 2025ë…� 6ì›� 3ì� ì˜¤ì „ 11ì‹�(ë™ë¶€ 시간)ì—� ì˜ˆì •ë˜ì–´ 있습니다.
발표 ì¤� DavisëŠ� 회사ì� ì „ëžµ, 성과 ë°� 현재 시장 ë™í–¥ì—� 대í•� ë…¼ì˜í•� ì˜ˆì •ìž…ë‹ˆë‹�. 투ìžìžë“¤ì€ Questì� 투ìžìž� ê´€ê³� 페ì´ì§€ ir.QuestDiagnostics.comì� 통해 ë¼ì´ë¸� 웹ìºìŠ¤íŠ¸ë¥� 시ì²í•� ìˆ� 있습니다. 녹화ë� ë²„ì „ì€ í–‰ì‚¬ í›� 24시간 ì´ë‚´ì—� ì œê³µë˜ë©° 2025ë…� 7ì›� 3ì¼ê¹Œì§€ ì ‘ê·¼í•� ìˆ� 있습니다.
Quest Diagnostics (NYSE : DGX) a annoncé que son président, PDG et président Jim Davis donnera une présentation lors de la 45e conférence annuelle William Blair sur les actions de croissance à Chicago. La présentation est prévue pour le 3 juin 2025 à 11h00 heure de l'Est.
Lors de la présentation, Davis abordera la stratégie de l'entreprise, ses performances et les tendances actuelles du marché. Les investisseurs pourront accéder à la diffusion en direct via la page des relations investisseurs de Quest à l'adresse ir.QuestDiagnostics.com. La version archivée sera disponible dans les 24 heures suivant l'événement et restera accessible jusqu'au 3 juillet 2025.
Quest Diagnostics (NYSE: DGX) gab bekannt, dass Vorstandsvorsitzender, CEO und Präsident Jim Davis eine Präsentation auf der William Blair 45. jährlichen Growth Stock Conference in Chicago halten wird. Die Präsentation ist für den 3. Juni 2025 um 11:00 Uhr Eastern Time geplant.
Während der Präsentation wird Davis die Unternehmensstrategie, die Leistung und aktuelle Markttrends erläutern. Investoren können den Live-Webcast über die Investor-Relations-Seite von Quest unter ir.QuestDiagnostics.com verfolgen. Die archivierte Version wird innerhalb von 24 Stunden nach der Veranstaltung verfügbar sein und bis zum 3. Juli 2025 zugänglich bleiben.
- None.
- None.
The presentation session will be webcast live during the conference on the company's investor relations page, which can be accessed at . In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until July 3, 2025.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
Ìý
View original content to download multimedia:
SOURCE Quest Diagnostics